Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Glyburide measurement |
Component |
False |
Glyburide |
Inferred relationship |
Some |
|
Poisoning by glibenclamide |
Causative agent (attribute) |
False |
Glyburide |
Inferred relationship |
Some |
|
Accidental poisoning by glibenclamide |
Causative agent (attribute) |
False |
Glyburide |
Inferred relationship |
Some |
|
Intentional poisoning by glibenclamide |
Causative agent (attribute) |
False |
Glyburide |
Inferred relationship |
Some |
|
Poisoning caused by glibenclamide of undetermined intent |
Causative agent (attribute) |
False |
Glyburide |
Inferred relationship |
Some |
|
Glibenclamide adverse reaction |
Causative agent (attribute) |
False |
Glyburide |
Inferred relationship |
Some |
|
Allergy to glibenclamide (finding) |
Causative agent (attribute) |
False |
Glyburide |
Inferred relationship |
Some |
|
Overdose of glibenclamide |
Causative agent (attribute) |
False |
Glyburide |
Inferred relationship |
Some |
|
Accidental overdose by glibenclamide |
Causative agent (attribute) |
False |
Glyburide |
Inferred relationship |
Some |
|
Intentional overdose by glibenclamide |
Causative agent (attribute) |
False |
Glyburide |
Inferred relationship |
Some |
|
surdose de glibenclamide d'intention indéterminée |
Causative agent (attribute) |
False |
Glyburide |
Inferred relationship |
Some |
|
Glibenclamide 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyburide |
Inferred relationship |
Some |
|
Glibenclamide 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyburide |
Inferred relationship |
Some |
|
Glibenclamide 1.25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyburide |
Inferred relationship |
Some |
|
Glibenclamide micronised 3 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyburide |
Inferred relationship |
Some |
|
Product containing precisely glibenclamide micronized 6 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyburide |
Inferred relationship |
Some |
|
Glibenclamide micronised 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyburide |
Inferred relationship |
Some |
|
Glibenclamide micronised 4.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyburide |
Inferred relationship |
Some |
|
Glibenclamide 6.3 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyburide |
Inferred relationship |
Some |
|
Product containing glibenclamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyburide |
Inferred relationship |
Some |
|
Product containing glibenclamide and metformin hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyburide |
Inferred relationship |
Some |
|
Glibenclamide 1.25 mg and metformin hydrochloride 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyburide |
Inferred relationship |
Some |
|
Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyburide |
Inferred relationship |
Some |
|
Glibenclamide 5 mg and metformin hydrochloride 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyburide |
Inferred relationship |
Some |
|
Accidental poisoning by glibenclamide |
Causative agent (attribute) |
False |
Glyburide |
Inferred relationship |
Some |
|
Intentional poisoning by glibenclamide |
Causative agent (attribute) |
False |
Glyburide |
Inferred relationship |
Some |
|